Funding · Company
Consano Bio, Inc.
Burlington, MABiotech & Pharma
Consano Bio, Inc. of Burlington, MA has disclosed $35M across 1 Form D offering filed with the SEC on Mar 20, 2026.
$35M
Total disclosed
1
Form D offering
2024
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$35M
Form D · Mar 20, 2026 ↗
Q1 2026
· target $49M
Filing details
HeadquartersBurlington, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2024SEC CIK0001981285Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →